Laparoscopic procedures in patients with cardiac ventricular assist devices
- 112 Downloads
Cardiac left ventricular assist device (LVAD) placement is a common therapy for heart failure. Non-cardiac surgical care of these patients can be complex given the need for anticoagulation, perioperative monitoring, comorbidities, and anatomical considerations due to the device itself. There are no guidelines or significant patient series reported to date for laparoscopic procedures in this population. We herein report the techniques and outcomes for commonly performed laparoscopic procedures in patients with LVADs at a high volume center.
From our database of patients with ventricular assist devices, we retrospectively identified patients who underwent laparoscopic abdominal surgery. Intraoperative and perioperative data were collected, including anticoagulation management, transfusions and complications. Techniques and preoperative considerations from the surgeons were also compiled and described.
Of 374 patients that had placement of LVADs, 17 had an elective laparoscopic procedure: enteral access placement (n = 7), cholecystectomy (n = 6), hernia repair (n = 2), small bowel resection (n = 1) and splenectomy (n = 1). Preoperative evaluation routinely included radiologic imaging to evaluate driveline location. The most common abdominal entry technique was a periumbilical open Hasson technique (11/17). No cases were converted to open. Overall, the average blood loss was 132 ± 64 mL and the average operative time was 1.8 ± 0.3 h. Five of the 17 patients required intraoperative blood transfusion. No patients suffered perioperative thrombotic events or LVAD complications secondary to holding anticoagulation. No patients required interventions or reoperation for bleeding complications. There were no mortalities related to these procedures.
Laparoscopic abdominal procedures are safe and feasible in patients with LVADs. Although special consideration for bleeding and thrombotic risks, placement of ports and perioperative management is required, the presence of a LVAD itself should not be considered a contraindication for laparoscopic surgery and may in fact be the preferred method for access in these patients.
KeywordsLVAD VAD Ventricular assist device Anticoagulation Driveline
Compliance with ethical standards
Dr. Jeevanandam is an advisor for Thoratec/Abbott. Dr. Uriel is an advisor for Thoraec/Abbott and HeartWare/Medtronic. Dr Yalini Vigneswaran, Dr Victoria Wang, Dr Monika Krezalek, Dr Vivek Prachand, Dr Stephen Wyers, Ms Colleen Juricek, and Dr Mustafa Hussain have no conflicts of interest or financial ties to disclose.
- 1.Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443. https://doi.org/10.1056/NEJMoa012175 CrossRefGoogle Scholar
- 6.Brown JB, Hallinan WM, Massey HT, Bankey PE, Cheng JD, Stassen NA, Sangosanya AT, Gestring ML (2009) Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome? Surgery 146(4):627–633. https://doi.org/10.1016/j.surg.2009.06.033. (discussion 633–634)CrossRefGoogle Scholar
- 9.Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N (2010) Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 90(4):1270–1277. https://doi.org/10.1016/j.athoracsur.2010.04.093 CrossRefGoogle Scholar
- 10.Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ, Moazami N (2007) Late-onset driveline infections: the Achilles’ heel of prolonged left ventricular assist device support. Ann Thorac Surg 84(2):515–520. https://doi.org/10.1016/j.athoracsur.2007.03.085 CrossRefGoogle Scholar
- 11.Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP (2014) Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant 33(1):51–59. https://doi.org/10.1016/j.healun.2013.10.005 CrossRefGoogle Scholar
- 13.Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH (2005) Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 24(1):105–109. https://doi.org/10.1016/j.healun.2003.10.018 CrossRefGoogle Scholar
- 15.Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancin D (2010) Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 56(15):1207–1213. https://doi.org/10.1016/j.jacc.2010.05.016 CrossRefGoogle Scholar
- 16.Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8):849–853. https://doi.org/10.1016/j.healun.2011.03.008 Google Scholar
- 17.John R, Kamdar F, Eckman P, Colvin-Adams M, Boyle A, Shumway S, Joyce L, Liao K (2011) Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg 92(5):1593–1599. https://doi.org/10.1016/j.athoracsur.2011.06.081. (discussion 1599–1600)CrossRefGoogle Scholar
- 19.Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L (2009) Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 137(1):208–215. https://doi.org/10.1016/j.jtcvs.2008.07.032 CrossRefGoogle Scholar
- 21.Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N (2010) Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 90(4):1263–1269. https://doi.org/10.1016/j.athoracsur.2010.04.099. (discussion 1269)CrossRefGoogle Scholar
- 22.Steinlechner B, Dworschak M, Birkenberg B, Duris M, Zeidler P, Fischer H, Milosevic L, Wieselthaler G, Wolner E, Quehenberger P, Jilma B (2009) Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg 87(1):131–137. https://doi.org/10.1016/j.athoracsur.2008.10.027 CrossRefGoogle Scholar